ISG‐expressing cDC2s have been shown to present tumour antigens to CD8+ T cells via a process called “cross‐dressing”, where they acquire intact peptide:MHC‐I complexes from cancer cells [28, 29]. The gene discussed is CD8A; the disease is cancer.